皇朝家居(01198.HK)擬成立合營企業
格隆匯5月6日丨皇朝家居(01198.HK)公佈,於2022年5月6日,公司(i)與鎧耀生物醫藥科技(管理)有限公司("鎧耀生物醫藥管理",連同其附屬公司,"目標集團")就可能成立合營企業("可能成立合營企業")訂立意向書及(ii)與鎧耀生物醫藥管理的附屬公司鎧耀環境衞生科技(BVI)有限公司("目標公司")就可能投資目標公司股權("可能投資")訂立意向書("意向書(B)")。該等投資須以注資方式進行。倘目標集團及╱或目標公司於2022年6月30日或之前未收到投資款項,則意向書(A)及意向書(B)將吿失效。
據悉,目標公司為一家於英屬處女羣島註冊成立的有限公司。其主要從事投資控股。目標公司為鎧耀生物醫藥管理的一家附屬公司,致力於為公共空間提供新一代清潔、消毒及滅菌技術基礎設施。其專注於公共衞生及感染控制,為公共交通運輸及商業領域提供包括諮詢、訂製解決方案及技術培訓在內的全套服務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.